We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Lumen Bioscience, a clinical-stage biopharma company, announced results from a research collaboration with Google that applied machine learning (ML) to significantly advance the scalability of spirulina-based biologic drugs.
Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologics for highly prevalent diseases, has entered into a research collaboration with Novo Nordisk to evaluate Lumen's drug development and manufacturing platform in ...